These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12737772)

  • 1. Asthma: resource use and costs for inhaled corticosteroid vs leukotriene modifier treatment--a meta-analysis.
    Halpern MT; Khan ZM; Stanford RH; Spayde KM; Golubiewski M
    J Fam Pract; 2003 May; 52(5):382-9. PubMed ID: 12737772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
    Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C
    J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities.
    O'Connor RD; Parasuraman B; Roberts C; Leibman C
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):236-43. PubMed ID: 16937758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate.
    Lage MJ; Gross GN; Brewster C; Spalitto A
    Adv Ther; 2009 Aug; 26(8):762-75. PubMed ID: 19669630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of recurrent emergency department visits or hospitalizations in children with asthma receiving nebulized budesonide inhalation suspension compared with other asthma medications.
    McLaughlin T; Leibman C; Patel P; Camargo CA
    Curr Med Res Opin; 2007 Jun; 23(6):1319-28. PubMed ID: 17559731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist.
    Stempel DA; Pinto L; Stanford RH
    J Allergy Clin Immunol; 2002 Jul; 110(1):39-41. PubMed ID: 12110816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β
    Pavord ID; Mathieson N; Scowcroft A; Pedersini R; Isherwood G; Price D
    NPJ Prim Care Respir Med; 2017 Mar; 27(1):17. PubMed ID: 28270657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis.
    Armstrong EP; Malone DC
    Pharmacotherapy; 2002 Sep; 22(9):1117-23. PubMed ID: 12222547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma.
    Lafeuille MH; Dean J; Zhang J; Duh MS; Gorsh B; Lefebvre P
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):59-64. PubMed ID: 22727159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
    Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
    Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene modifier use and asthma severity: how is a new medication being used by adults with asthma?
    Snyder L; Blanc PD; Katz PP; Yelin EH; Eisner MD
    Arch Intern Med; 2004 Mar; 164(6):617-22. PubMed ID: 15037489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Outcomes, Health Care Resource Use, and Costs Associated with High Versus Low HEDIS Asthma Medication Ratio.
    Luskin AT; Antonova EN; Broder MS; Chang E; Raimundo K; Solari PG
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1117-1124. PubMed ID: 29083971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma.
    Stempel DA; Meyer JW; Stanford RH; Yancey SW
    J Allergy Clin Immunol; 2001 Jan; 107(1):94-8. PubMed ID: 11149997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
    MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting UK primary-care costs of managing patients with asthma over 5 years.
    Dasgupta R; Guest JF
    Pharmacoeconomics; 2003; 21(5):357-69. PubMed ID: 12627989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost implications for the use of inhaled anti-inflammatory medications in the treatment of asthma.
    Ozminkowski RJ; Wang S; Marder WD; Azzolini J; Schutt D
    Pharmacoeconomics; 2000 Sep; 18(3):253-64. PubMed ID: 11147392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma hospitalization risk and costs for patients treated with fluticasone propionate vs montelukast.
    Orsini L; Limpa-Amara S; Crown WH; Stanford RH; Kamal K
    Ann Allergy Asthma Immunol; 2004 May; 92(5):523-9. PubMed ID: 15191020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
    Allen-Ramey FC; Duong PT; Riedel AA; Markson LE; Weiss KB
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
    Busse W; Wolfe J; Storms W; Srebro S; Edwards L; Johnson M; Bowers BW; Rogenes PR; Rickard K
    J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.